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Abstract 
Malta, the smallest country in the European Union, is experiencing a demographic transition where the share of 
individuals aged 65-plus currently makes up 16.3% of the total population. This figure is projected to reach 31.2% 
by 2060. While the opportunity to grow older indicates social success, it creates important challenges at both the 
personal and political economy levels. As a result of this increase in the number of older persons, age-related 
neurodegenerative disorders, including the most common forms of dementia, are expected to rise proportionately. 
This will pose significant societal demands as most dementia care is provided informally by family members living 
in the community. Furthermore, recent studies have shown that there is considerable lack of awareness and 
professional training that is seriously undermining timely diagnosis and management. As a result, Malta opted to 
take a holistic approach towards dementia care by recently launching a long-term strategy focusing on increasing 
awareness, providing the best services leading to high quality dementia care, and fostering dementia training to 
healthcare professionals in order to be better equipped to support individuals with dementia. It is a vision that 
promotes excellence, and effectively reflects the current and future needs of these individuals, their relatives and 
caregivers. 
 
                                                                      
 
Introduction 
 
Dementia is a group of brain disorders characterized by progressive deterioration of cognitive function. It is the 
most common neurological disorder in old age and a major predictor of morbidity and mortality in the elderly. The 
most common form of dementia is Alzheimer’s disease (AD). Other types include vascular dementia, dementia with 
Lewy bodies, fronto-temporal dementia and dementia secondary to disease [1]. 
 
Dementia affects individuals in different ways depending on the type and stage of disease progression [2]. Early-
stage dementia is often missed or misdiagnosed due to lack of awareness that often leads to the belief that the 
observed symptoms are a direct consequence of the normal ageing process. Common signs at this stage include 
impairment of short-term memory, difficulty in verbal communication and decision making, difficulty in carrying out 
complex activities of daily living (ADL) and changes in mood and behaviour including depression and anxiety. As 
the disease progresses to subsequent stages, individuals become more forgetful, have increased difficulty in 
communication, are unable to perform basic ADL and live independently and may display inappropriate behaviour 
such as wandering, hallucinations and disinhibition [2]. The amount of informal caring for an individual with 
dementia is also related to the severity of the condition with half of the caregivers spending more than ten hours a 
day in caring for an individual with late-stage dementia compared to 20% for early-stage dementia [3]. For most 
progressive dementias, no cure exists that stops or reverses the observed brain cell death. Treatments available to 
date are mostly approved for AD and are intended to delay the decline in cognitive symptoms for a limited amount 
of time [4]. Treatment for the common changes in behaviour depends on the presenting symptoms which vary from 
one individual to another. These are usually the most challenging and distressing characteristic of the disease 
process and include agitation, anxiety, verbal and nonverbal aggression, hallucinations, delusions and sleep 
disturbances [5]. 
 
According to Alzheimer’s Disease International, the total number of people with dementia worldwide is projected to 
almost double every twenty years reaching 75.6 million in 2030 and 135.5 million in 2050 [6]. Much of this increase 
is attributed to low- and middle-income countries, and driven by population growth and demographic ageing [7]. The 
global societal costs of dementia are enormous as the total estimated worldwide expenditure for the year 2010 was 
calculated to reach US$604 billion, equivalent to 1% of the world’s gross domestic product [8]. The cost of care 
provided by families (informal care) together with societal care (care provided by professional personnel in home 
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settings) contribute to 42% of the costs worldwide, while direct medical care accounts to 16% of the overall costs. 
Interestingly, low-income countries account to around 1% of the global dementia costs whereas high-income 
countries account to 89% [8]. 
 
In the recent years, the European Union (EU) has devoted particular attention to the medical, social and financial 
aspects of dementia. Research on neurodegenerative disorders has been strengthened as part of the Health 
Theme within FP7 (2007-2013) with special reference to brain research and particular emphasis placed on 
translational research and the development of new drugs. The Public Health Programme also supported the 
European Collaboration on Dementia (EuroCoDe) project coordinated by Alzheimer Europe in order to achieve a 
comprehensive overview of the present situation in terms of prevalence, diagnosis, treatment, and socio-economic 
costs of AD in EU-member states. Results from this project indicated that 7.3 million individuals live with dementia 
in the European Union [9]. In January 2011, the European Parliament adopted a resolution calling for dementia to 
be made an EU health priority and urging member states to develop dedicated national plans and strategies with 
the aim of addressing the social and health consequences, as well as services and support for affected individuals 
and their family members. Taking action against dementia through various intervention streams such as 
strengthening capacity, leadership, governance, risk reduction, public awareness and facilitating technological and 
social innovations was one of the main recommendations put forward by the World Health Organization (WHO) in 
its first Ministerial Conference on Global Action Against Dementia organized at the beginning of 2015.  The latter 
was an aftermath of the progress made since the 2013 G8 Dementia Summit which called WHO and the 
Organization for Economic Co-operation and Development (OECD) to identify dementia as an increasing threat to 
global health and support countries to strengthen health and social care systems to improve care and services for 
people with dementia. 
 
As a consequence of the need to address the challenge of dementia, Malta embarked on a nationwide consultation 
process, starting in 2009, with the aim of developing a holistic approach towards dementia care through a policy 
document that focuses on a number of intervention streams including an increase in awareness and understanding 
of dementia, workforce development, providing the best services leading to high quality dementia care, and 
fostering dementia training to healthcare professionals in order to be better equipped to support individuals with 
dementia. The policy document was published and officially launched at the beginning of April 2015 making Malta 
the 21st
 
country to have a national dementia plan worldwide. 
 
 
 
Malta: demography and healthcare system 
 
The Maltese archipelago (315 km²) consists of three main islands: Malta, Gozo and Comino. It is located in the 
centre of the Mediterranean Sea with Sicily 93 km to the north and northern Africa 288 km to the south. The latest 
available data show that the total population of Malta in 2013 was estimated at 425,384 of which just over half were 
females [10]. 
 
Malta scores high on the Human Development Index with a life expectancy of 79.2 years for males and 83.6 years 
for females (Table 1). Circulatory diseases are the leading cause of death accounting to 40% of all deaths followed 
by 27% for neoplasms [10]. Diabetes is highly prevalent in Malta, a pattern shared with other Mediterranean 
countries. 
 
Health care in Malta is provided through two systems: statutory and private. Health care in the public sector is 
highly centralized and regulated. The government delivers primary health care through a number of health centres 
that offer a full range of preventive, curative and rehabilitative services. In secondary and tertiary care, specialized 
ambulatory care is provided in public outpatient clinics and health centres. The ministry responsible for health 
finances, regulates and acts as service provider for public hospitals. A number of private hospitals are also 
available. In 2013, there were 422 physicians, 741 nurses and midwives, and 245 pharmacists per 100,000 
population [10].  
 
In the recent years, medicines and medical devices have been the fastest-growing component of public health care 
expenditure in Malta, the latter totaling 8.6% of the national gross domestic product in 2010. This is mostly due to 
ever-increasing medical care needs and the advent of new generations of drugs and products. The government 
supplies medicines listed in the hospital drug formulary free of charge to all in-patients in public hospitals. Other 
individuals entitled to free medication include pink and yellow card holders. Pink card holders (also referred to as 
Schedule II patients) benefit under the Medical Aids Grant of the Malta Social Security Act and entitlement is based 
on the total household income. Yellow card holders (also referred to as Schedule V patients) are individuals with a 
specific chronic condition listed in the Fifth Schedule of the Social Security Act. Dementia was included as one of 
the conditions in this list in 2012 with the subsequent introduction of the acetylcholinesterase inhibitor donepezil in 
the drug formulary. 
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Table 1.  Life expectancy (LE), healthy life expectancy (HLE) and years lived with disability (YD) at birth based on 
mortality in Malta in 2005 and 2010 according to gender. Adapted from [11] 
 
 
  LE HLE YD 
Men 2005 77.2 68.6 8.6 
 2010 79.2 70.2 9.0 
  
Women 2005 81.4 70.4 11.0 
 2010 83.6 71.6 12.0 
 
 
 
Malta: an ageing population  
 
Current projections indicate that Malta will be one of the fastest ageing countries in the European Union. The 
Economic Policy Commission’s Ageing Report 2012 shows that the economic repercussions of this increase are 
also intensifying due to the interplay of longevity and shrinking of the labour force [12]. The effective economic age-
dependency ratio in Malta is projected to increase by 47% from 2010 to 2060, reaching 85%. The share of the 
population aged 65-plus in Malta is set to increase by 16.1% between 2010 and 2060, to reach 31.2%. The share of 
the population aged 80-plus population in relation to the population aged 15-64 will increase by 7.9%. This will 
result in an increase of the old-age dependency ratio from 24.1% in 2010 to 60.9% in 2060 [12]. 
 
The healthy life expectancy, based on mortality and morbidity combined data, shows an increase of 0.7 years for 
Maltese men aged 65 between 2005 and 2010. During the same period, an increase in healthy life expectancy of 
0.9 years was observed for Maltese women at the age of 65, which in 2010 stood at 71.6 years and was the highest 
healthy life expectancy of women at birth in the EU. Healthy life expectancy of the Maltese men is ranked second 
highest. In 2011 healthy life expectancy at birth of women and men stood at 70.7 years and 70.3 years respectively, 
while its analogue at the age of 65 stood at 11 years for women and 11.8 years for men. This means that those 
men, who survive till the age of 65, have actually more healthy years of life than women at the age of 65. 
Considering men's overall shorter expectation of life, this makes a significant relative impact [11]. 
 
The United Nations probabilistic population projections, the 2010 revision based on the probabilistic projections of 
total fertility and life expectancy at birth, provide a range of values for the Maltese population between 2010 and 
2060 [13]. From the data, it looks evident that there is much less uncertainty in the 65-plus projections where the 
absolute gap is less wide. This is due to the high life expectancy levels already achieved and no influence of fertility 
changes in these projected cohorts [11]. While the population aged 65-plus is projected to grow, the total population 
is declining rapidly from 2030 onwards. This results in an increase in the share of persons aged 65-plus in the total 
population, which reaches 37% in 2060. This is of particular significance in dementia where increased age is the 
most important non-modifiable risk factor. 
 
 
 
Dementia in Malta  
 
The first study to determine the prevalence rates of dementia in the Maltese Islands was published in 2007 [14]. 
Using the European Community Concerted Action on the Epidemiology and Prevention of Dementia (EURODEM) 
data methodology, it reported that in 2050, the number of individuals with dementia would reach 6,369, accounting 
to 2% of the Maltese population. This data was revised in another study published in 2012 [15] using the latest 
prevalence rates as reviewed by the EuroCoDe project (Table 2). The results showed that the estimated number of 
individuals with dementia in the Maltese Islands in 2010 was 5,198; a significant increase from the previous 
predicted data. Likewise, the number of dementia individuals over the age 60 in 2030 is projected to be close to 
10,000 or 2.3% of the total population. Thus the 2% estimate will be reached in 2025, twenty-five years prior to what 
was previously reported. This discrepancy between the two prevalence set of data originates mostly from the 
oldest-old age groups, the latter being underreported in previous estimation studies. The significant increase 
reaching 3.6% of the Maltese population over the next fifty years will invariably put greater demands on the already 
stretched national health care services resulting in considerable socioeconomic consequences.  
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Table 2.  Estimated number of gender-specific dementia cases in the Maltese Islands according to age groups 
using EuroCoDe data for the years ranging from 2010 to 2060. Data shown as M/F (M: males; F: females) 
 
 
Year 
Age 
groups 
2010 2015 2020 2030 2040 2050 2060 
60-64 30/139 27/124 27/127 21/100 27/123 29/127 25/105 
65-69 179/154 240/201 223/186 217/177 198/164 234/193 246/185 
70-74 242/346 246/344 381/513 376/493 292/391 382/488 419/507 
75-79 367/577 419/601 446/616 671/871 677/847 639/800 777/959 
80-84 448/834 493/945 620/1038 1100/1672 1154/1681 946/1380 1306/1784 
>85 483/1399 619/1812 750/2248 1164/3021 2012/4806 2337/5400 2356/5368 
Total IWD 5198 6071 7175 9881 12372 12957 14037 
% of the 
population 
1.24 1.47 1.73 2.37 3.04 3.26 3.62 
 
 
 
 
State-run services for individuals with dementia and their caregivers are limited and currently not meeting the 
demands of the ever increasing number of diagnosed dementia cases. There are only two specially designed 
dementia wards, both manned by healthcare staff specifically trained in person-centred dementia care. Located 
within the premises of the largest long-term residential care facility in Malta is the dementia activity centre which 
was launched in 2007 and provides an opportunity of social interaction for residents and non-residents with 
dementia. Rehabilitation services, a Memory Clinic, respite care and a Dementia Helpline are also offered by staff 
comprising interdisciplinary healthcare professionals. With few exceptions, none of the privately owned residential 
homes are dedicated to solely cater for the needs of individuals with dementia. In late 2012, in conjunction with the 
introduction of donepezil in the government formulary list, there was the setting up of dementia clinics in the 
community intended to offer support to the already existing Memory Clinic and the Cognitive Behavioural Disorders 
Clinic within the Neurology Department. Although free drug entitlement is only authorized by consultant 
geriatricians, neurologists and psychiatrists in patients with a Mini Mental State Examination score ranging from 13-
26, all treatment options are available as an out-of-pocket expense from community pharmacies following 
prescription by any medical practitioner. To date, no protocol exists on the use of medication to control the 
behavioural and psychological symptoms of dementia (BPSD) experienced by the majority of these individuals. 
Interestingly, these drugs are rarely used in Malta among in-patients with dementia [16].  
 
Dementia awareness and support in the community mostly comes from the Malta Dementia Society. This non-
governmental, non-profit organization was launched in 2004 with the aim of increasing awareness on dementia 
care and management in the Maltese Islands through the organization of talks and seminars for individuals with 
dementia, their caregivers and healthcare professionals. Another important aim of the society is that of 
collaborating with the central health and social care authorities to improve and design new services that enhance 
the quality of life of individuals with dementia. As previously highlighted, most of the dementia care is provided by 
family members in the community. A study on the organization of dementia care in the Maltese Islands found 
significant difficulties in providing care for a relative with dementia [17]. Of particular interest is the fact that families 
have developed a rotating care pattern to accommodate individual family member’s social and working life while 
still maintaining responsibility. Caregivers views of formal services were dismissive as to their lack of suitability for 
their or relatives’ needs. This research continues to emphasize the need of expanding support services for people 
with dementia and their carers in the community. 
 
 
 
Dementia policy development in Malta 
 
Given the huge burden of dementia, the challenges facing governments worldwide are considerable. In these last 
few years, there has been an increase in recognizing the extent of this problem and the need to take action. Apart 
from Malta, only a few countries have dementia plans and policies in action that address the key medical, social 
www.nuclmed.gr                                               Hellenic Journal of Nuclear Medicine   January-April 2015 (Suppl) 6 
and financial aspects that dementia pose on the society in general [7]. Priority areas for action common to these 
plans include increase in dementia awareness, access to social and health care, training of the workforce, support 
to informal caregivers, ethical and legal issues and enhancing research into prevention and treatment [7]. In the 
beginning of 2009, the Malta Department of Health through its Parliamentary Secretariat for the Elderly and 
Community Care launched the National Dementia Strategy Group with the aim of identifying a number of 
recommendations that would provide a strategic framework in order to deliver quality improvements in local 
dementia services and address any local shortfalls in dementia care [18]. This group was composed of an 
interdisciplinary team coming from the medical and allied health care professions together with representatives of 
the society. The work undertaken included (a) detailed analysis of services that are available to individuals with 
dementia and their caregivers, (b) consultation process with stakeholders working in the field of dementia 
management and care including professional bodies, and (c) questionnaire designed for the public in order to 
obtain information regarding the various aspects of informal dementia care. The findings together with the 
recommendations were presented to the health authorities in January of 2010.  
 
Analysis of the dementia situation in Malta reported considerable lack of support at all levels of dementia care 
together with a dearth of healthcare staff professionally trained in dementia patient-centred care. Services available 
were not tailored for the needs of these individuals, their family members and caregivers especially if the person 
with dementia is still relatively young. Professional training at undergraduate and postgraduate level mostly focused 
on the medical model with very limited emphasis on social models of care. Basic awareness among the general 
population was found to be lacking with most individuals adopting a wait-and-see approach towards seeking 
professional advice [18].  
 
The consultation process involved professional and nonprofessional stakeholders and included contact groups 
coming from the education sector (including academic bodies representing tertiary education), medical and allied 
healthcare representatives, acute and long-term health and social service providers and the community. The 
general public was invited to participate by sending feedback via a specifically drawn-up anonymous questionnaire 
that was available online and composed of twenty-five multiple choice questions analyzing the various aspects of 
dementia care within the community setup (Table 3). The topics focused on awareness and training, early 
intervention, government-supported structures and services, community support and end-of-life issues. A total of 
613 completed questionnaires were analyzed as part of the report. Respondents were in the majority females and 
consisted of healthcare professionals, main carers, family members with no main caring role, individuals with 
dementia and other members of the public. The age of participants ranged between 30 and 70 years [18].  
 
With respect to awareness and training, results demonstrated that dementia is not considered as a taboo subject 
among dementia caregivers, relatives and healthcare professionals even though the same categories pointed 
towards significant lack of public awareness. Issues hindering individuals suspecting dementia from seeking 
professional assistance included the belief that the symptoms will resolve with time, the presence of stigma that 
may lead to social discrimination and the assurance that such symptoms are part of the normal ageing process. 
Only a third of the respondents pointed out that healthcare professionals have the necessary training and skills in 
dementia care highlighting the need to enhance training in the various aspects of dementia management and care, 
possibly adopting a multidisciplinary approach that embraces both the medical and the social model. 
 
In the majority of European countries, dementia is not diagnosed early in the diseases process and a significant 
time lag exists between observing the first symptoms and diagnosis. This is mostly due to lack of training among 
medical professionals necessary to identify the initial symptoms of dementia. During the stakeholders meetings, 
dementia caregivers expressed their concerns on the lack of advice and appropriate information at the point of 
diagnosis. Data from the public questionnaire exercise indicated a significant degree of reluctance to seek medical 
assistance following the appearance of the first dementia symptoms with a third waiting for more than six months 
before asking for advice. Stakeholders’ intervention on issues relating to the availability of state-run services 
denoted a significant lack of basic infrastructure that provides adequate support to individuals with dementia. The 
number of purposely-built dementia units did not meet the demand and more community services were required to 
limit early admission to long-term nursing care. Furthermore, carers and healthcare professionals working with 
individuals with dementia pointed towards the need to be supported at all levels to prevent physical and 
psychological burnout.  
 
The significant majority of individuals who participated in the questionnaire agreed on the importance of respite 
care provision. Even though the dementia activity centre was offering assistance in terms of providing respite to 
carers and a socially engaging environment to individuals with dementia, the service was relatively unpopular. 
Studies show that most individuals with dementia live within the community [17]. This is of great significance in a 
small country like Malta in which senior citizens continue to live within the family structure. Due to the progressive 
nature of the most common forms of dementia, affected individuals can still remain active, especially in the early 
stages of the disease. Recommendations by stakeholders included the provision of good-quality community 
services that would defer institutionalization, psychological support for informal carers in coping with stress of 
continuous care, dementia-designed home care services, financial assistance in purchasing assistive technology 
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and an increase in the carer’s pension as dementia costs are significantly higher compared to other medical 
conditions. 
 
 
 
Table 3.  Percentage response from different categories of respondents (all categories, n=613) to a sample of 
questions on various aspects of dementia (n/a: no answer). Adapted from [18] 
 
 
  
yes no 
don't 
know n/a 
Is there enough awareness on carer/relative 24.7 69.0 5.8 0.6 
dementia? individual with dementia 17.7 64.7 17.7 0.0 
 healthcare professional 19.1 77.9 2.2 0.9 
 others 26.7 51.8 19.9 1.6 
      
Is there enough information on  carer/relative 23.0 64.4 11.5 1.2 
services that are available for individual with dementia 23.5 47.1 23.5 5.9 
individuals with dementia? healthcare professional 17.3 71.4 9.5 1.7 
 others 18.3 55.0 22.0 4.7 
      
Do healthcare professionals have  carer/relative 44.8 25.9 25.3 4.0 
the necessary skills in dementia individual with dementia 47.1 17.7 29.4 5.9 
management? healthcare professional 30.3 49.8 12.1 7.8 
 others 34.6 20.9 34.6 10.0 
      
Do you consider community care  all categories 88.4 1.0 3.1 7.5 
as important?      
      
Do you consider respite care as  all categories 85.6 0.3 5.4 8.6 
important?      
      
Does dementia impact on family all categories 77.5 3.1 4.7 14.6 
finances?      
 
 
 
 
As expected, the majority of participants to the questionnaire considered community and respite care as important. 
Furthermore, caring for an individual with dementia has a significant impact on family finances. Other issues that 
were explored included palliative care, end-of-life issues and ethical approaches to dementia management and 
care. Unfortunately, there is a lack of these services all across Europe [19] even though such provision of care is 
routinely offered to terminally-ill cancer patients and that palliative management preserves the dignity of the 
individual and supports family members in coping with bereavement. Lack of knowledge in this particular area was 
felt in the feedback obtained from the public with a significant number of respondents indicating lack of knowledge 
on such themes. Although dementia raises a number of ethical concerns for individuals with dementia and the 
society as a whole, such issues have not yet been addressed. The report presented to the health authorities in 
2010 included recommendations aimed at:  
 
(a) Improving awareness of dementia in the community  
(b) Facilitating early diagnosis and intervention 
(c) Providing information at the point of diagnosis and beyond 
(d) Increasing knowledge of services that are already available  
(e) Enhancing the quality of care in acute and long-term settings  
(f) Strengthen community support services 
(g) Providing end-of-life support services  
(h) Adopting an ethical approach in dementia management and care. 
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Although the national dementia strategy has been launched only recently, positive initiatives in these last years 
comprised the availability of one anti-dementia medication for free by the government, collection of data on the 
number of dementia cases, increased awareness through the publication of a number of information booklets and 
training sessions on dementia care to healthcare professionals and support staff working with individuals with 
dementia in long-term residential/nursing homes. In 2013, the Maltese government appointed a National Focal 
Point on Dementia with the aim of advising the local authorities on measurements that need to be adopted in order 
to improve the quality of lives of individuals with dementia, their caregivers and family members. This included the 
drafting of a dementia strategy for the Maltese Islands. 
 
In recent years, a number of research initiatives were conducted in order to explore the level of local professional 
workforce knowledge on dementia management and care. Education and training of healthcare professionals are 
major requisites not only in enhancing awareness, timely diagnosis and service delivery but also in reaching the 
critical mass necessary to effectively implement the recommendations laid down in the policy document. Most 
often, knowledge on dementia at undergraduate level is variable, fragmented and lacks focus on the social issues 
involved in the various stages of disease progression. The old medical model is too restricted to respond effectively 
to the multifaceted and diverse nature of the condition. 
 
The knowledge and attitudes of nursing students towards dementia has recently been investigated [20]. Because of 
the upward shift in the number of individuals with dementia, a significant portion of nursing students will come into 
direct contact with these individuals during their clinical placement and succeeding graduation. Apart from textbook 
knowledge, nursing professionals need to internalize positive attitudes towards individuals with dementia in order to 
lessen the negative stereotypes associated with this particular condition. The overall findings show that nursing 
students in Malta had adequate knowledge of dementia (Table 4) even though they lack information on dementia 
risk factors and caregiving issues. A positive relationship was reported between perceived satisfaction of their 
experience during clinical placement and attitude. The students’ age was found to be an important factor on the 
degree of dementia knowledge and attitude scores with older students obtaining the highest values. In conclusion, 
this study highlighted the need for a better theoretical and experiential preparation in dementia care for Maltese 
nursing students. This can be achieved by introducing more training that focuses on learning needs possibly 
through the use of predefined case scenarios and role playing.  
 
 
 
Table 4.  Mean Alzheimer’s Disease Knowledge Scale (ADKS) and Dementia Attitude Scale (DAS) scores 
according to year of study among Maltese nursing students (n=280, 61.3% response rate) 
 
 
 
Mean scores 
First 
year 
Second 
year 
Third 
year 
All 
participants 
ADKS 
(Maximum score: 30) 
18.35 19.88 20.18 19.36 
DAS 
(7-point Likert scale) 
101.18 105.98 102.30 103.51 
 
 
 
Research on dementia in primary care is limited even though general practitioners (GPs) act as first point of contact 
for individuals suspecting memory problems and thus have an important role in ensuring timely diagnosis. 
Notwithstanding the considerable drive in promoting educational programmes aimed at primary care levels, 
dementia remains largely under diagnosed [21] even though there is a consensus among healthcare professionals 
that early diagnosis is beneficial to the patient and helps in delaying institutionalization. Lack of training in 
recognizing the initial signs of dementia is one of the underlying factors as well as the confounding symptomatic 
profile. GPs are also not comfortable with disclosing dementia citing concerns that include erroneous diagnosis and 
psychological distress. Similar trends were also observed in a study investigating practices in diagnosis, disclosure 
and pharmacotherapeutic management of dementia among Maltese GPs [22]. In the majority of cases, participating 
practitioners felt that they do not have enough training and skills in diagnosing dementia even though most of them 
correctly recognized that memory and behavioural difficulties are important symptomatic signs that accompany the 
condition. This may have led to a number of practitioners adopting a wait-and-see approach to diagnosis with a 
consequent delay in early management options. Therapeutic nihilism was observed in those GPs with fifteen years 
or more experience in general practice thus creating a niche whereby individuals with dementia are getting 
undiagnosed and unmanaged. In contrast with other countries, referral to dementia specialists was considered only 
by a very small number of Maltese GPs presumably leading to a lower catchment rate compared to geriatricians, 
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neurologists and psychiatrists. Dementia disclosure is uncommon with local GPs and when it occurs, the patient is 
rarely consulted. Preferences of drug interventions shifted depending on the level of cognitive deficit and years of 
working experience in primary practice. The general use of medication to control the behavioural symptoms of 
dementia was found to be low and varied depending on disease progression (Table 5). The overall picture obtained 
through this study was that GPs need more training on managing dementia in the community. Given its unique 
geographical characteristics with close-knit communities, GPs working in Malta are in direct and constant close 
contact with their patients and thus may act as role players in providing improved quality care to affected individuals 
and their carers [22]. A need is also felt in providing continuing educational programmes in order for these 
professionals to be in a better position to face the growing number and increased needs of individuals with 
dementia in primary care. 
 
 
 
Table 5.  General practitioners (GPs) (n=193, 54.2% response rate) responses on Alzheimer’s disease (AD) 
pharmacotherapy (AChEIs: acetylcholinesterase inhibitors). Supplements included ginkgo-containing agents, 
nootropics and vitamin E 
 
 
 
  
Percentage 
of GPs 
What drug treatment would you 
consider as first choice? 
Mild AD 
AChEIs 
Benzodiazepines 
All-class antidepressants 
All-class antipsychotics 
Memantine 
Supplements 
No response 
Moderate AD 
AChEIs 
Benzodiazepines 
All-class antidepressants 
All-class antipsychotics 
Memantine 
Supplements 
No response 
Severe AD 
AChEIs 
Benzodiazepines 
All-class antidepressants 
All class antipsychotics 
Memantine 
Supplements 
No response 
  
47.7 
0.0 
4.1 
0.5 
3.1 
36.3 
8.3 
  
64.2 
0.0 
3.1 
1.0 
11.4 
10.4 
9.8 
  
40.4 
3.6 
2.6 
3.6 
31.1 
4.1 
14.5 
 
 
 
 
Empowering change 
 
In April of 2015, Malta officially launched its national dementia strategy entitled ‘Empowering change: a national 
strategy for dementia in the Maltese Islands (2015-2023)’. It highlights various measures that need to be 
implemented in order to enhance the quality of life of individuals with dementia, their caregivers and family 
members. The multifaceted nature of dementia necessitates a multidisciplinary approach to dementia management 
and care. The vision of this strategy is for people in various sectors of society to come together and create a system 
whereby individuals with dementia have access to the support and care they require. Dementia also has a profound 
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effect on relatives and caregivers and thus the policy document also aims to address their needs as part of the 
holistic approach to dementia care. 
 
The strategy outlines a number of actions that are necessary in the different priority areas of dementia management 
and care (Table 6). These include an increase in awareness and understanding of dementia, the provision of timely 
diagnosis, the availability of a trained workforce, improving dementia management and care, promoting an ethical 
approach to dementia care as well as strengthening research in this field. It is also the result of a wide consultation 
exercise with the general public and stakeholders representing various sectors of dementia management and care. 
This ensures that the national strategy for dementia is a living document which encompasses a strong commitment 
from all those involved in order to empower change and make a true difference in the lives of people living with 
dementia. 
 
 
 
Table 6.  Streams of actions, objectives and main recommendations of the National Strategy for Dementia in the 
Maltese islands (2015-2023) 
 
 
 
Actions Objectives Main recommendations 
   
Increase awareness 
and understanding of 
dementia 
Changing the perception of 
dementia 
Encourage help seeking 
Provide guidance 
Continuing information campaigns  
Appointing Dementia Activists 
Online guide on dementia caregiving 
Promote the work of civil society 
organizations 
Strengthening of the Dementia Helpline 
Timely diagnosis and 
intervention 
Improve diagnosis at an 
early stage 
Provide information on 
available services upon 
diagnosis 
Timely access to care 
Promote the value of early diagnosis in 
primary care 
Enhance training in dementia diagnosis, 
disclosure and management to primary care 
physicians 
Setting up of Dementia Intervention Teams 
Development and distribution of information 
at the point of diagnosis and beyond 
Workforce 
development 
Ensure health and social 
care professionals working 
with individuals with 
dementia receive 
specialized training 
Provision of dementia patient-centred care 
training to the workforce 
Supporting information technology platforms 
that facilitate online training 
Continuous professional development 
programmes 
 
Improving dementia 
management and care 
Availability of all dementia 
medications on the drug 
formulary 
Improve care delivery 
Provide community support 
Implementation of 
dementia-friendly measures 
Full access to medication and regular review 
Establishing training opportunities in non-
pharmacological methods 
Ensure individuals with dementia have a care 
plan 
Involvement of all stakeholders in decision 
taking 
Increase respite facilities 
Implementation of dementia-friendly design 
Availability of palliative care support 
Ensuring the necessary quality standards in 
residential/nursing settings 
Ethical approach to 
care 
Promote an ethical 
approach to dementia 
management and care 
Provision of training in ethical decision taking, 
respect for personhood and wellbeing 
Promoting the use of advanced directives 
Provision of psychological support services 
Adoption of the ‘partners in care’ approach 
Monitoring of abuse 
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Research Promote and foster 
research in the field of 
dementia 
Ensure that dementia becomes a national 
research priority 
Facilitate access to clinical trials 
Enhanced participation in European and pan-
European research projects on dementia 
 
 
 
 
Implementation of this policy document is scheduled to start in 2015 and run till 2023. Due to the challenging nature 
of dementia, this exercise will entail substantial investment in human, financial, technical and infrastructural 
resources. However, the gradual delivery of the objectives is projected to have a considerable positive impact on 
the quality of life of individuals with dementia, their family members and caregivers. The latter are carrying an 
enormous burden and thus require more solidarity from the government and society in general. Implementation of 
the measures set out aims to create a system whereby all individuals with dementia have access to the care and 
support they require.  
 
The objectives laid down will also need the extension of a trained workforce in order to deliver new and improved 
services. It will also require joint planning and working between health and social care staff, policy makers, 
individuals with dementia, their families and caregivers. Continuous assessment of the outcomes, including real-life 
experiences of individuals with dementia, will ensure that the objectives set out in this document are met. 
Assessment should also seek the views of caregivers and healthcare staff. Since important gender differences exist 
across various aspects of dementia, with women mostly affected both in prevalence and caregiving [23], the 
implementation strategy will also strive to provide a gender dimension in its deliverables.  
 
During the implementation process, a number of gaps may become apparent. Interim evaluations are thus 
necessary to gather new information and assess the usefulness of different projects being proposed in the various 
areas of dementia care. This will aid in further detailed planning of long-term objectives. Moreover, the 
implementation exercise is expected to reveal other important needs that will require assessment and further plans 
to adequately address them. A national team will be needed to coordinate and oversee the implementation process. 
Individuals with dementia, their family members, caregivers and policy makers all expect to see progress in a cost-
effective way. It is therefore important that the results achieved are regularly communicated to the general public in 
an efficient and comprehensible manner. 
 
 
 
Conclusion 
 
There is little doubt that dementia will pose one of the greatest societal and health challenges that must be 
addressed nationally as well as at personal and family level. In general, there is a significant lack of awareness, 
training and support services in many aspects of dementia management and care in Malta. This is to be expected, 
considering that meaningful discussion on dementia at a national level kicked off only in these last few years. The 
huge costs of the disease will challenge health systems worldwide with the predicted increase in the prevalence 
rates in line with an ageing population. Dementia is also overwhelming for family carers who often feel that they are 
left to fend on their own due to the lack of adequate support that promotes independence and wellbeing. 
Community support is needed to enable informal carers to continue in their caring role for as long as possible and 
should involve respite services and financial support. Moreover, training for healthcare professionals should be 
expanded and include multidisciplinary educational programmes focusing on patient-centred dementia 
management and care. The organization of effective campaigns that enhance public understanding of dementia will 
not only reduce misconceptions, stigma and discrimination but will invariably aid in timely diagnosis and help 
seeking. Political commitment is needed to generate and implement policies that work for these individuals and for 
those who care for them. The launch of a national dementia strategy aimed at holistically addressing important 
issues relating to increase in awareness, enhanced training for informal carers and healthcare professionals, and 
provision of the much required services at community level will undoubtedly have a positive impact on the quality of 
life of individuals with dementia in Malta.  
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